AMITROLE JMPR 1977 Explanation Amitrole was evaluated in 1974 (FAO/WHO, 1975). A conditional acceptable daily-intake for humans of 0.00003 mg/kg b.w. was established. Since then some new information has become available, EVALUATION FOR ACCEPTABLE DAILY INTAKE BIOCHEMICAL ASPECTS Metabolism 3-Amino-1,2,4 triazole (5-14C) was administered orally to rats as a single dose of 5 mg/kg body weight. The main part of the radioactivity (about 79%) was excreted in the urine during the first 24 hrs. After three days about 6% of the total dose was excreted as metabolites. The two main metabolites were identified as 3-amino-5-mercapto-1,2,4 triazole (I) and 3-amino-1,2,4-traizo-5-yl-mercapturic acid (II). In the faeces only 1.5% of the dose was excreted.Metabolite I has in its tautomeric form the -NH-CS-NH-group, which was thought to be partly responsible for the antithyroid action of amitrole. However, according to the authors amitrole has much more effect on the thyroid than 3-amino-5-mercapto-triazole (Grunow et al., 1975). TOXICOLOGICAL STUDIES Special studies on mutagenicity The LD50 of amitrole for Drosophila was 40 ppm in the medium, while with 10 ppm a prolongation of development time was found. Therefore no optimal concentrations for a mutagenicity test could be used. With 10 ppm in the medium no mutagenic effects were observed in the sex chromosome non-disjunction test (females) or the sex-linked recessive lethal test (males) (Laamanen et al., 1976). Effects of amitrole on human leucocytes in culture were investigated. The cell growth was inhibited in concentrations of 0.2%w/v and higher. Selected metaphases were examined for the presence of chromosome and chromatid aberrations. No breakage or other visible chromosome damage has been found (Meretoja at al., 1976). With bacteria two types of tests were carried out. A DNA repair test was done with E. coli, B. subtilis and S. typhimurium strains. No mutagenic effect was noted. Negative results were also obtained in a revertant test with several strains of Salmonella. In both types of test known mutagens were used as positive controls (Bamford et al., 1976), Special studies on carcinogenicity 40 female Wistar rats were given 2500 ppm amitrole in the drinking water during their life-time. All animals surviving 30-70 weeks were studied. In all animals goitre was observed. After 30 weeks the follicles became small and stromal tissue became fibrotic. These small follicles contained little or no colloid. The proliferating follicular tissue gave invasive lesions in 19 of the 26 rats. In 3 of the animals nodules of papillary adenoma were found. In the liver two cases of cholangiofibrosis, clue to irregular proliferation of the bile ducts and surrounding stroma, were found (Tsuda et al., 1976). Special studies on the antithyroid effect Two dosages of amitrole (0.5 g/kg and 1.0 g/kg) were administered intraperitoneally to chicks, daily from day 3-40 after hatching. The animals showed growth inhibition and an increased thyroid/body weight ratio, compared with the controls. In another experiment chicks were injected up to day 20 post-hatching at which time treatment with the drug was discontinued. The animals were sacrificed at day 27, 34, and 41. When the amitrole treatment was stopped, the thyroid/body weight ratio decreased markedly, but never to the same levels which were obtained in the controls. Histologically, the characteristic changes reported for other goitrogens were observed in the thyroid (Wishe, 1976). Short-term studies Rat Several short-term experiments were carried out in order establish a no-effect level on thyroid function tests. In all experiments the uptake of 131I by the thyroid was measured in an in vivo test, 6, 24 and 48 hours after administration of 0.6 µc 131I per animal intraperitoneally. In addition thyroid weight and PBI (protein bound iodine) were measured and the thyroid was studied histopathologically. In the first experiment 4 groups of 8 female Wistar rats received respectively 0, 2, 20 and 200 ppm of amitrole in the diet during 6 weeks. After 5 days and 6 weeks the uptake of 131I was measured. At both times a significantly increased uptake was found in the 200 ppm group 6 hours after injection, which decreased rather rapidly after 24 and 48 hrs. At that time the radioactivity was lower than that of the controls. The thyroid weight was increased in the 200 ppm group and histopathologically goitre was found in this group only. In the two lower dosages no significant effects were found. In the second experiment in which 8 female animals per group received respectively 0, 20, 50 and 200 ppm for 6 weeks, the same effect was found in the 200 ppm group. In addition a significantly decreased PBI was observed at the end of the experiment. With 50 ppm in the diet for 6 weeks a statistically increased uptake was found 6 hours after injection of 131I. In this case the radioactivity in the thyroid remained higher than the controls after 24 and 48 hrs. Histopathologically only a very slight activation was found, whereas 200 ppm showed strong activation and goitre. In the third experiment 0, 20, 50 and 200 ppm were given to 10 animals per group during 13 weeks. The uptake of 131I by the thyroid was significantly increased at 200 and 50 ppm after 6 and 12 weeks. The difference between the groups was that with 50 ppm the radioactivity in the thyroid remained high after 24 and 48 hrs., whereas with 200 ppm a very high uptake was found 6 hrs. after injection of 131I, but a rapid decrease still lower than the controls after 48 hrs. With 200 ppm the PBI was decreased and the thyroid/body weight ration increased by a factor of 6. With 50 ppm only a slightly increased relative thyroid weight was found. Histologically a strong activation and goitre were found with 200 ppm a slight activation with 50 ppm. In this experiment a tendency to a higher uptake of 131I was found in the 20 ppm group. The above mentioned experiments were carried out with a relatively low iodine content in the diet (about 0.2-0.3 ppm). In the fourth experiment an iodine content of about 2 ppm was used. In this experiment 8 female rats per group received respectively 0, 20, 50, 200 and 500 ppm in the diet for 6 weeks, to see whether iodine could protect against the anti-hyroid action of amitrole. With 500 ppm a small increase in iodine uptake was found 5 hrs. after 131I injection, but thereafter a very rapid decrease. With 200 ppm the uptake was much higher and the same type of decrease was found as in the other experiments, whereas with 50 ppm a significantly increased thyroid radioactivity was found at all times. The 131I uptake of all animals was of course much lower than in the increased and PBI only decreased at 200 and 500 ppm. Histopathologically goitre and strongly activated thyroids were found only at the two highest dosed levels. Some activation was found in the 50 ppm group and a very slight activation was also found in the 20 ppm group. (Den Tonkelaar and Kroest 1974) COMMENTS Several new studies on mutagenicity became available. No mutagenic action could be demonstrated. In a recent carcinogenicity study with a very high dose level, which had an influence on survival, a carcinogenic action on the thyroid was found. In addition, two cases of cholangiofibrosis in the liver have been observed. Two metabolites of amitrole have been identified after oral administration to rats. In four short-term studies the main effect was an increased uptake of radioactive iodine by the thyroid at dose levels of 50, 200 and 500 ppm. This uptake correlated well with the histologically observed activation. With 20 ppm only a very marginal effect was found while 2 ppm was without effect. This Meeting confirmed the existing conditional ADI for humans pending consideration of the whole concept of conditional ADIs for humans at a future meeting. FURTHER WORK OR INFORMATION Desirable See FAO/WHO Pesticide residues in food. Report of the 1974 Joint Meeting of the FAO Working Party of Experts on Pesticide Residues and the WHO Expert Committee on Pesticide Residues. p. 31 REFERENCES Bamford, D., Sorsa, M., Gripenberg, U., Laamanen, I. and Meretoja, T. (1976) Mutagenicity and toxicity of amitrole III. Microbial tests Mutation Res 401, 197-202. Den Tonkelaar, E.M. and Kroes, R. (1974) Schildklierfunctieonderzoek na subacute en semichronische toediening van aminotriazol. Unpublished report National Institute of Public Health, Bilthoven, the Netherlands, 164/74 Tox. Grunow, W., Altmann, H.J. and Böhme, CHR. (1975) Uber Den Stoffwechsel von 3-Amino-1,2,3-triazol in Ratten. Arch. Toxicol. 34, 315-324. Laamanen, J., Sorsa, M., Banford, D., Gripenberg, U. and Meretoja, T. (1976) Mutagenicity and toxicity of amitrole I. Drosophila tests. Mutation Res. 40, 185-190. Meretoja, T., Gripenberg, U., Bamford, B., Laamanen, I. and Sorsa, M. (1976) Mutagenicity and toxicity of amitrole II. Human lymphocyte culture tests. Mutation Res. 40, 191-196 Tsuda, H., Hananouchi, M., Tatematsu, M., Hirose, M., Hirao, K., Takahashi, M. and Ito, N. (1976) Tumorigenic effect of 3-amino-1-H-1,2,3 triazole on rat thyroid. J. Natl. Cancer Inst. 57, 861-864. Wishe, H.J. (1976) The effect of aminotriazole on the thyroid gland and development of the white leghorn chicks. Diss. Abstr. Int. B., 37, 1066-1067. Cited in Rest. Abstr. 9, (1976). FAO/WHO (1975) 1974 evaluations of some pesticide residues in food. AGP: 1974/M/11; WHO Pesticide Residue Series, No. 4.
See Also: Toxicological Abbreviations Amitrole (EHC 158, 1994) Amitrole (HSG 85, 1994) Amitrole (ICSC) Amitrole (WHO Pesticide Residues Series 4) Amitrole (Pesticide residues in food: 1993 evaluations Part II Toxicology) Amitrole (Pesticide residues in food: 1997 evaluations Part II Toxicological & Environmental) Amitrole (IARC Summary & Evaluation, Supplement7, 1987) Amitrole (IARC Summary & Evaluation, Volume 7, 1974) Amitrole (IARC Summary & Evaluation, Volume 41, 1986) Amitrole (IARC Summary & Evaluation, Volume 79, 2001)